The effect of centaurein on interferon-γ expression and Listeria infection in mice

Toxicology and Applied Pharmacology

Volumn 219, Issue 1, 2007, Pages 54-61

  Chang, Shu Lin ^a,b   Yeh, Hsu Hua ^a,b   Lin, Yu Shiun ^a   Chiang, Yi Ming ^a   Wu, Tung Kung ^b   Yang, Wen Chin ^a  

^a AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Centaurein; Flavonoid; IFN ; Listeria

Indexed keywords

AMPICILLIN; CENTAUREIN; FLAVONOID; GAMMA INTERFERON; INTERLEUKIN 4; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LISTERIA; LISTERIOSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SINGLE DRUG DOSE; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BIDENS; ELECTROPORATION; FLAVONOIDS; GLUCOSIDES; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; LUCIFERASES; MACROPHAGES; MEDICINE, TRADITIONAL; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; STIMULATION, CHEMICAL; T-LYMPHOCYTES;

LISTERIA; MUS;

EID: 33846902830     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.026     Document Type: Article

References (35)

1. Andrade R.M., Portillo J.A., Wessendarp M., and Subauste C.S. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates. Infect. Immun. 73 (2005) 3115-3123
2. Buchwald U.K., and Pirofski L. Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Curr. Pharm. Des. 9 (2003) 945-968
3. Calder J.A. Listeria meningitis in adults. Lancet 350 (1997) 307-308
4. Chang C.L.T., Kuo H.K., Chang S.L., Chiang Y.M., Lee T.H., Wu W.M., Shyur L.F., and Yang W.C. The distinct effects of a butanol fraction of Bidens pilosa plant extract on the development of Th1-mediated diabetes and Th2-mediated airway inflammation in mice. J. biomed. Sci. 12 (2005) 79-89
5. Chiang Y.M., Chuang D.Y., Wang S.Y., Kuo Y.H., Tsai P.W., and Shyur L.F. Metabolite profiling and chemopreventive bioactivity of plant extracts from Bidens pilosa. J. Ethnopharmacol. 95 (2004) 409-419
6. Dorman S.E., and Holland S.M. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev. 11 (2000) 321-333
7. Edelson B.T., and Unanue E.R. Immunity to Listeria infection. Curr. Opin. Immunol. 12 (2000) 425-431
8. Facinelli B., Giovanetti E., Varaldo P.E., Casolari P., and Fabio U. Antibiotic resistance in foodborne Listeria. Lancet 338 (1991) 1272
9. Geissberger P., and Sequin U. Constituents of Bidens pilosa L.: do the components found so far explain the use of this plant in traditional medicine?. Acta Trop. 48 (1991) 251-261
10. Haak-Frendscho M., Young K.M., and Czuprynski C.J. Treatment of mice with human recombinant interleukin-2 augments resistance to the facultative intracellular pathogen Listeria monocytogenes. Infect. Immun. 57 (1989) 3014-3021
11. Hubel K., Dale D.C., and Liles W.C. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J. Infect. Dis. 185 (2002) 1490-1501
12. Hwang E.S., Szabo S.J., Schwartzberg P.L., and Glimcher L.H. T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307 (2005) 430-433
13. Jones E.M., Howe R.A., and MacGowan A.P. Treatment of Listeria meningitis. Lancet 350 (1997) 1034
14. Kaufmann S.H. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11 (1993) 129-163
15. Kaufmann S.H., Hahn H., Berger R., and Kirchner H. Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity. Eur. J. Immunol. 13 (1983) 265-268
16. Kurtz R.S., Young K.M., and Czuprynski C.J. Separate and combined effects of recombinant interleukin-1 alpha and gamma interferon on antibacterial resistance. Infect. Immun. 57 (1989) 553-558
17. Lighvani A.A., Frucht D.M., Jankovic D., Yamane H., Aliberti J., Hissong B.D., Nguyen B.V., Gadina M., Sher A., Paul W.E., and O'Shea J.J. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 15137-15142
18. MacGowen A.P., Reeves D.S., and McLauchlin J. Antibiotic resistance of Listeria monocytogenes. Lancet 336 (1990) 513-514
19. Rabe T., and van Staden J. Antibacterial activity of South African plants used for medicinal purposes. J. Ethnopharmacol. 56 (1997) 81-87
20. Rengarajan J., Mittelstadt P.R., Mages H.W., Gerth A.J., Kroczek R.A., Ashwell J.D., and Glimcher L.H. Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 12 (2000) 293-300
21. Roll J.T., Young K.M., Kurtz R.S., and Czuprynski C.J. Human rTNF alpha augments anti-bacterial resistance in mice: potentiation of its effects by recombinant human rIL-1 alpha. Immunology 69 (1990) 316-322
22. Rouquette C., and Berche P. The pathogenesis of infection by Listeria monocytogenes. Microbiologia 12 (1996) 245-258
23. Sica A., Dorman L., Viggiano V., Cippitelli M., Ghosh P., Rice N., and Young H.A. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 272 (1997) 30412-30420
24. Steinmuller C., Roesler J., Grottrup E., Franke G., Wagner H., and Lohmann-Matthes M.L. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int. J. Immunopharmacol. 15 (1993) 605-614
25. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
26. Townsend M.J., Weinmann A.S., Matsuda J.L., Salomon R., Farnham P.J., Biron C.A., Gapin L., and Glimcher L.H. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20 (2004) 477-494
27. van Ogtrop M.L., Mattie H., Sekh B.R., van Strijen E., and van Furth R. Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice. Antimicrob. Agents Chemother. 36 (1992) 2375-2380
28. Way S.S., and Wilson C.B. Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet. J. Immunol. 173 (2004) 5918-5922
29. Wilson R.L., Tvinnereim A.R., Jones B.D., and Harty J.T. Identification of Listeria monocytogenes in vivo-induced genes by fluorescence-activated cell sorting. Infect. Immun. 69 (2001) 5016-5024
30. Xu X., Sun Y.L., and Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273 (1996) 794-797
31. Yamaoka Y., Kawakita T., Kishihara K., and Nomoto K. Effect of a traditional Chinese medicine, Bu-zhong-yi-qi-tang on the protection against an oral infection with Listeria monocytogenes. Immunopharmacology 39 (1998) 215-223
32. Yamaoka Y., Kawakita T., and Nomoto K. Protective effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to), on the restraint stress-induced susceptibility against Listeria monocytogenes. Immunopharmacology 48 (2000) 35-42
33. Yamaoka Y., Kawakita T., and Nomoto K. Protective effect of a traditional Japanese medicine Hochu-ekki-to (Chinese name: Bu-zhong-yi-qi-tang), on the susceptibility against Listeria monocytogenes in infant mice. Int. Immunopharmacol. 1 (2001) 1669-1677
34. Yang W.C., Ching K.A., Tsoukas C.D., and Berg L.J. Tec kinase signaling in T cells is regulated by phosphatidylinositol 3-kinase and the Tec pleckstrin homology domain. J. Immunol. 166 (2001) 387-395
35. Ye J., Cippitelli M., Dorman L., Ortaldo J.R., and Young H.A. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol. Cell. Biol. 16 (1996) 4744-4753